Life Sciences Next-generation Customer Engagement Platforms Market Size, Share & Trends Analysis Report By Component (Software, Services), By Deployment Mode, By Functionality, By End Use, By Region, And Segment Forecasts, 2025 - 2033
Description
Life Sciences Next-generation Customer Engagement Platforms Market Summary
The global life sciences next-generation customer engagement platformsmarket size was estimated at USD 2.37 billion in 2024 and is projected to reach USD 5.56 billion by 2033, growing at a CAGR of 10.13% from 2025 to 2033. Healthcare providers increasingly focus on personalized care, necessitating advanced engagement platforms to tailor interactions and enhance patient outcomes.
Growing need for customized interactions with healthcare professionals and patients, driving the development and implementation of advanced CEP solutions. The shift toward patient-centric care is accelerating demand for life sciences next-generation customer engagement platforms, as companies need digital tools that go beyond product promotion to deliver continuous support, education, and outcomes-focused engagement. For instance:
In October 2024, Temedica and Roche extended their successful partnership, benefiting tens of thousands of patients with digital companion apps like Retinora for retinal diseases and Brisa for multiple sclerosis. These apps, built on Temedica’s platform and integrated with real-world evidence, provide personalized support that improves patient care, with ongoing expansions planned.
In March 2022, DarioHealth entered into a multi-year, USD 30 million strategic agreement with Sanofi U.S. to accelerate the commercial adoption of Dario's digital therapeutics platform and expand digital health solutions. The collaboration aims to promote Dario’s multi-condition digital therapeutics, increase sales reach in health plan and employer markets, and jointly develop new solutions to improve chronic disease management.
In September 2021, Genentech (Roche) deployed Lifelink Systems’ AI-powered chatbot to improve patient communication in clinical trials. This demonstrated the need for platforms that can manage 24/7, scalable, and compliant patient touchpoints, which directly fuels CEP adoption.
These instances demonstrate how the industry is incorporating patient-centered approaches into engagement strategies. As digital companions, AI chatbots, and digital therapeutics collaborations grow, life sciences companies are compelled to adopt advanced customer engagement platforms that integrate these tools, support compliant interactions, and deliver measurable value across the care ecosystem, ultimately fueling market growth.
Global Life Sciences Next-generation Customer Engagement Platforms Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global life sciences next-generation customer engagement platforms market report based on component, deployment mode, functionality, end use, and region:
The global life sciences next-generation customer engagement platformsmarket size was estimated at USD 2.37 billion in 2024 and is projected to reach USD 5.56 billion by 2033, growing at a CAGR of 10.13% from 2025 to 2033. Healthcare providers increasingly focus on personalized care, necessitating advanced engagement platforms to tailor interactions and enhance patient outcomes.
Growing need for customized interactions with healthcare professionals and patients, driving the development and implementation of advanced CEP solutions. The shift toward patient-centric care is accelerating demand for life sciences next-generation customer engagement platforms, as companies need digital tools that go beyond product promotion to deliver continuous support, education, and outcomes-focused engagement. For instance:
In October 2024, Temedica and Roche extended their successful partnership, benefiting tens of thousands of patients with digital companion apps like Retinora for retinal diseases and Brisa for multiple sclerosis. These apps, built on Temedica’s platform and integrated with real-world evidence, provide personalized support that improves patient care, with ongoing expansions planned.
In March 2022, DarioHealth entered into a multi-year, USD 30 million strategic agreement with Sanofi U.S. to accelerate the commercial adoption of Dario's digital therapeutics platform and expand digital health solutions. The collaboration aims to promote Dario’s multi-condition digital therapeutics, increase sales reach in health plan and employer markets, and jointly develop new solutions to improve chronic disease management.
In September 2021, Genentech (Roche) deployed Lifelink Systems’ AI-powered chatbot to improve patient communication in clinical trials. This demonstrated the need for platforms that can manage 24/7, scalable, and compliant patient touchpoints, which directly fuels CEP adoption.
These instances demonstrate how the industry is incorporating patient-centered approaches into engagement strategies. As digital companions, AI chatbots, and digital therapeutics collaborations grow, life sciences companies are compelled to adopt advanced customer engagement platforms that integrate these tools, support compliant interactions, and deliver measurable value across the care ecosystem, ultimately fueling market growth.
Global Life Sciences Next-generation Customer Engagement Platforms Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global life sciences next-generation customer engagement platforms market report based on component, deployment mode, functionality, end use, and region:
- Component Outlook (Revenue, USD Million, 2021 - 2033)
- Software
- Services (implementation, integration, support)
- Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
- Cloud / SaaS (multi-tenant, subscription)
- On-premise
- Functionality Outlook (Revenue, USD Million, 2021 - 2033)
- Core Engagement Layers
- End to end content management
- Engagement channel optimization
- Commercial learning and training
- Advanced Software Capabilities
- Cognitive Capabilities
- Functional Role Coverage
- Sales
- Marketing
- Medical Affairs
- Market Access
- Patient Services
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Medical Device Firms
- Others (Including Research Institutes, etc.)
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
190 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Component
- 1.2.2. Deployment Mode
- 1.2.3. Functionality
- 1.2.4. End use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR’s Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Shift toward patient-centered care
- 3.2.1.2. Adoption of digital transformation in healthcare
- 3.2.1.3. Demand for personalized customer engagement
- 3.2.1.4. Integration of AI and machine learning
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High Implementation Costs
- 3.2.2.2. Data Privacy and Regulatory Compliance
- 3.2.3. Industry Opportunity Analysis
- 3.2.4. Industry Challenge Analysis
- 3.2.5. Case Studies
- 3.3. Business Environment Analysis
- 3.3.1. Porter’s Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal Landscape
- Chapter 4. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Component Estimates & Trend Analysis
- 4.1. Component Segment Dashboard
- 4.2. Component Market Share Movement Analysis, 2024 & 2033
- 4.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
- 4.4. Software
- 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Services (implementation, integration, support)
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Deployment Estimates & Trend Analysis
- 5.1. Deployment Segment Dashboard
- 5.2. Deployment Market Share Movement Analysis, 2024 & 2033
- 5.3. Market Size & Forecasts and Trend Analysis, by Deployment, 2021 to 2033 (USD Million)
- 5.4. Cloud / SaaS (multi-tenant, subscription)
- 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. On-premise
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Functionality Type Estimates & Trend Analysis
- 6.1. Functionality Type Dashboard
- 6.2. Functionality Market Share Movement Analysis, 2024 & 2033
- 6.3. Market Size & Forecasts and Trend Analysis, by Functionality, 2021 to 2033 (USD Million)
- 6.4. Core Engagement Layers
- 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.2. End to end content management
- 6.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.3. Engagement channel optimization
- 6.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.4. Commercial learning and training
- 6.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Advanced Software Capabilities
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2. Cognitive Capabilities
- 6.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Functional Role Coverage
- 6.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3.2. Sales
- 6.5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3.3. Marketing
- 6.5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3.4. Medical Affairs
- 6.5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3.5. Market Access
- 6.5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3.6. Patient Services
- 6.5.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: End Use Estimates & Trend Analysis
- 7.1. End use Segment Dashboard
- 7.2. End use Market Share Movement Analysis, 2024 & 2033
- 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 7.4. Pharmaceutical Companies
- 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Biotechnology Companies
- 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Medical Device Firms
- 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Contract Research Organizations (CROs)
- 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8. Others (Including Research Institutes, etc.)
- 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Dashboard
- 8.2. Regional Market: Key Takeaways
- 8.3. North America
- 8.3.1. North America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key country dynamic
- 8.3.2.2. Regulatory framework
- 8.3.2.3. Competitive insights
- 8.3.2.4. U.S. Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key country dynamic
- 8.3.3.2. Regulatory framework
- 8.3.3.3. Competitive insights
- 8.3.3.4. Canada Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.3.4. Mexico
- 8.3.4.1. Key country dynamic
- 8.3.4.2. Regulatory framework
- 8.3.4.3. Competitive insights
- 8.3.4.4. Mexico Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4. Europe
- 8.4.1. Europe Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.2. Germany
- 8.4.2.1. Key country dynamic
- 8.4.2.2. Regulatory framework
- 8.4.2.3. Competitive insights
- 8.4.2.4. Germany Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.3. UK
- 8.4.3.1. Key country dynamic
- 8.4.3.2. Regulatory framework
- 8.4.3.3. Competitive insights
- 8.4.3.4. UK Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key country dynamic
- 8.4.4.2. Regulatory framework
- 8.4.4.3. Competitive insights
- 8.4.4.4. France Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key country dynamic
- 8.4.5.2. Regulatory framework
- 8.4.5.3. Competitive insights
- 8.4.5.4. Italy Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key country dynamic
- 8.4.6.2. Regulatory framework
- 8.4.6.3. Competitive insights
- 8.4.6.4. Spain Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.7. Denmark
- 8.4.7.1. Key country dynamic
- 8.4.7.2. Regulatory framework
- 8.4.7.3. Competitive insights
- 8.4.7.4. Denmark Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.8. Sweden
- 8.4.8.1. Key country dynamic
- 8.4.8.2. Regulatory framework
- 8.4.8.3. Competitive insights
- 8.4.8.4. Sweden Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Key country dynamic
- 8.4.9.2. Regulatory framework
- 8.4.9.3. Competitive insights
- 8.4.9.4. Norway Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Key country dynamic
- 8.5.2.2. Regulatory framework
- 8.5.2.3. Competitive insights
- 8.5.2.4. Japan Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.3. China
- 8.5.3.1. Key country dynamic
- 8.5.3.2. Regulatory framework
- 8.5.3.3. Competitive insights
- 8.5.3.4. China Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key country dynamic
- 8.5.4.2. Regulatory framework
- 8.5.4.3. Competitive insights
- 8.5.4.4. India Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. Key country dynamic
- 8.5.5.2. Regulatory framework
- 8.5.5.3. Competitive insights
- 8.5.5.4. South Korea Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.6. Australia
- 8.5.6.1. Key country dynamic
- 8.5.6.2. Regulatory framework
- 8.5.6.3. Competitive insights
- 8.5.6.4. Australia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.5.7. Thailand
- 8.5.7.1. Key country dynamic
- 8.5.7.2. Regulatory framework
- 8.5.7.3. Competitive insights
- 8.5.7.4. Thailand Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America Life Sciences Next-generation Customer Engagement Platforms (CEP) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Key country dynamic
- 8.6.2.2. Regulatory framework
- 8.6.2.3. Competitive insights
- 8.6.2.4. Brazil Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Key country dynamic
- 8.6.3.2. Regulatory framework
- 8.6.3.3. Competitive insights
- 8.6.3.4. Argentina Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7. MEA
- 8.7.1. MEA Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.2. South Africa
- 8.7.2.1. Key country dynamic
- 8.7.2.2. Regulatory framework
- 8.7.2.3. Competitive insights
- 8.7.2.4. South Africa Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.3. Saudi Arabia
- 8.7.3.1. Key country dynamic
- 8.7.3.2. Regulatory framework
- 8.7.3.3. Competitive insights
- 8.7.3.4. Saudi Arabia Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. Key country dynamic
- 8.7.4.2. Regulatory framework
- 8.7.4.3. Competitive insights
- 8.7.4.4. UAE Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Key country dynamic
- 8.7.5.2. Regulatory framework
- 8.7.5.3. Competitive insights
- 8.7.5.4. Kuwait Life Sciences Next-generation Customer Engagement Platforms (CEP) Market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Participant Overview
- 9.2. Company Market Position Analysis
- 9.3. Company Categorization
- 9.4. Strategy Mapping
- 9.5. Company Profiles/Listing
- 9.5.1. Aktana, Inc
- 9.5.1.1. Overview
- 9.5.1.2. Financial performance
- 9.5.1.3. Product benchmarking
- 9.5.1.4. Strategic initiatives
- 9.5.2. IQVIA (OCE)
- 9.5.2.1. Overview
- 9.5.2.2. Financial performance
- 9.5.2.3. Product benchmarking
- 9.5.2.4. Strategic initiatives
- 9.5.3. Veeva Systems
- 9.5.3.1. Overview
- 9.5.3.2. Financial performance
- 9.5.3.3. Product benchmarking
- 9.5.3.4. Strategic initiatives
- 9.5.4. Exeevo
- 9.5.4.1. Overview
- 9.5.4.2. Financial performance
- 9.5.4.3. Product benchmarking
- 9.5.4.4. Strategic initiatives
- 9.5.5. Pitcher
- 9.5.5.1. Overview
- 9.5.5.2. Financial performance
- 9.5.5.3. Product benchmarking
- 9.5.5.4. Strategic initiatives
- 9.5.6. Salesforce
- 9.5.6.1. Overview
- 9.5.6.2. Financial performance
- 9.5.6.3. Product benchmarking
- 9.5.6.4. Strategic initiatives
- 9.5.7. ACTO Technologies Inc.
- 9.5.7.1. Overview
- 9.5.7.2. Financial performance
- 9.5.7.3. Product benchmarking
- 9.5.7.4. Strategic initiatives
- 9.5.8. Allego
- 9.5.8.1. Overview
- 9.5.8.2. Financial performance
- 9.5.8.3. Product benchmarking
- 9.5.8.4. Strategic initiatives
- 9.5.9. Bigtincan
- 9.5.9.1. Overview
- 9.5.9.2. Financial performance
- 9.5.9.3. Product benchmarking
- 9.5.9.4. Strategic initiatives
- 9.5.10. ODAIA Intelligence Inc.
- 9.5.10.1. Overview
- 9.5.10.2. Financial performance
- 9.5.10.3. Product benchmarking
- 9.5.10.4. Strategic initiatives
- 9.5.11. Qstream, Inc.
- 9.5.11.1. Overview
- 9.5.11.2. Financial performance
- 9.5.11.3. Product benchmarking
- 9.5.11.4. Strategic initiatives
- 9.5.12. Seismic
- 9.5.12.1. Overview
- 9.5.12.2. Financial performance
- 9.5.12.3. Product benchmarking
- 9.5.12.4. Strategic initiatives
- 9.5.13. Tellius
- 9.5.13.1. Overview
- 9.5.13.2. Financial performance
- 9.5.13.3. Product benchmarking
- 9.5.13.4. Strategic initiatives
- 9.5.14. Viseven
- 9.5.14.1. Overview
- 9.5.14.2. Financial performance
- 9.5.14.3. Product benchmarking
- 9.5.14.4. Strategic initiatives
- 9.5.15. Vodori
- 9.5.15.1. Overview
- 9.5.15.2. Financial performance
- 9.5.15.3. Product benchmarking
- 9.5.15.4. Strategic initiatives
- 9.5.16. WhizAI
- 9.5.16.1. Overview
- 9.5.16.2. Financial performance
- 9.5.16.3. Product benchmarking
- 9.5.16.4. Strategic initiatives
- 9.5.17. ZS Associates
- 9.5.17.1. Overview
- 9.5.17.2. Financial performance
- 9.5.17.3. Product benchmarking
- 9.5.17.4. Strategic initiatives
- 9.5.18. Okra
- 9.5.18.1. Overview
- 9.5.18.2. Financial performance
- 9.5.18.3. Product benchmarking
- 9.5.18.4. Strategic initiatives
- 9.5.19. P360
- 9.5.19.1. Overview
- 9.5.19.2. Financial performance
- 9.5.19.3. Product benchmarking
- 9.5.19.4. Strategic initiatives
- 9.5.20. Quantified.ai
- 9.5.20.1. Overview
- 9.5.20.2. Financial performance
- 9.5.20.3. Product benchmarking
- 9.5.20.4. Strategic initiatives
- 9.5.21. verbTEAMS
- 9.5.21.1. Overview
- 9.5.21.2. Financial performance
- 9.5.21.3. Product benchmarking
- 9.5.21.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
